ViiV Healthcare showcases leadership in long-acting injectables innovation at CROI 2025 with data on third-generation integrase inhibitor and highly potent capsid inhibitor against HIV-1
| JENYX Fund | USD 56.38 0.70 1.26% |
Slightly above 50% of The Jensen's investors are presently thinking to get in. The analysis of overall sentiment of trading The Jensen Portfolio mutual fund suggests that some investors are interested at this time. The Jensen's investing sentiment can be driven by a variety of factors including economic data, The Jensen's earnings reports, geopolitical events, and overall market trends.
The |
LONDON, March 11, 2025--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from two phase IIa proof-of-concept studies of investigational antiretroviral therapies VH4524184 and VH4011499 . These findings, presented at the Conference on Retroviruses and Opportunistic Infections in San Francisco, U.S., support the continued development of these two compounds as distinct opt
Read at finance.yahoo.com
 |
The Jensen Fundamental Analysis
We analyze The Jensen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of The Jensen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Jensen based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Jensen Portfolio is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Jensen Portfolio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with The Jensen mutual fund to make a market-neutral strategy. Peer analysis of The Jensen could also be used in its relative valuation, which is a method of valuing The Jensen by comparing valuation metrics with similar companies.
Peers
The Jensen Related Equities
| CIPIX | Champlain Mid | 2.80 | ||||
| MIGNX | Massachusetts Investors | 1.94 | ||||
| HDGFX | The Hartford | 1.70 | ||||
| PDGIX | T Rowe | 1.68 | ||||
| JENIX | The Jensen | 1.26 |
Other Information on Investing in The Mutual Fund
The Jensen financial ratios help investors to determine whether The Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in The with respect to the benefits of owning The Jensen security.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |